Henning R. Stennicke
Director Técnico/Científico/I+D en FREELINE THERAPEUTICS HOLDINGS PLC .
Cargos activos de Henning R. Stennicke
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Director Técnico/Científico/I+D | 01/03/2022 | - |
Historial de carrera de Henning R. Stennicke
Antiguos cargos conocidos de Henning R. Stennicke.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Formación de Henning R. Stennicke.
| University of Copenhagen | Graduate Degree |
| Technical University of Denmark | Masters Business Admin |
Estadísticas
Internacional
| Dinamarca | 4 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Empresas privadas | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Henning R. Stennicke
- Experiencia
